Investor Relations

Company Overview

BioCorRx Inc. is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program developed by BioCorRx Inc. is a one-on-one proprietary counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. Additionally, we have expanded the support structure to include 12 months of a peer-support system utilizing trained recovery specialists. The company is also developing a patent pending injectable form of naltrexone.

Latest Financial Results

Q3 2016

Quarter Ended Sep 30, 2016

Stock Information

Symbol

OTCQB: BICX

Price

Change

Volume

52 week Low/High

Day Low/High

Contact Information

Investor Relations
Crescendo Communications, LLC
T: 212-671-1020 x304
bicx@crescendo-ir.com

investors@biocorrx.com

Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
www.vstocktransfer.com